CHAMPIONS ONCOLOGY, INC. (CSBR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US15870P3073
CHAMPIONS ONCOLOGY, INC. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 56.94 m USD | 59.43 m USD |
| Gross profit | 28.56 m USD | 28.53 m USD |
| Operating income | 4.55 m USD | -1.14 m USD |
| EBIT | 4.63 m USD | -929,000.00 USD |
| Net income | 4.70 m USD | -1.18 m USD |
| Diluted EPS – continuing operations | 0.33 USD | -0.08 USD |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CHAMPIONS ONCOLOGY, INC.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
More stocks
- HeXun Biosciences Co., Ltd. (6986.TWO)
- Morefield Group N.V. (MORE.AS)
- JUPITER NEUROSCIENCES, INC. (JUNS)
- Strong H Machinery Technology (Cayman) Incorporation (4560.TW)
- Gseven Co Ltd (2937.TWO)
- T&R Biofab Co. Ltd (246710.KQ)
- COGNITION THERAPEUTICS INC (CGTX)
- Integrated Solutions Technology, Inc. (6927.TWO)
- Pluk Phak Praw Rak Mae Public Company Limited (OKJ.BK)
- Datavan International (3521.TWO)
- SOLESENCE, INC. (SLSN)
- ALPHA PRO TECH LTD (APT)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.